Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule

EU orphan designation number: EU/3/09/709   
Active ingredient: Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule
Indication: Treatment of glioma
Sponsor: Apogenix GmbH
Im Neuenheimer Feld 584, D-69120 Heidelberg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2010 Centralised Orphan - Designation EMEA/OD/098/09 (2010)657 of 28/01/2010